Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck, Stallergenes race to FDA with new allergy treatments
Merck, Stallergenes race to FDA with new allergy treatments
Merck, Stallergenes race to FDA with new allergy treatments
Submitted by
admin
on August 2, 2010 - 8:15pm
Source:
Fierce Biotech
News Tags:
Merck
Stallergenes
FDA
allergies
Grazax
Oralair
sublingual treatments
Headline:
Merck, Stallergenes race to FDA with new allergy treatments
Do Not Allow Advertisers to Use My Personal information
